Cellectis Gross Profit from 2010 to 2024

CLLS Stock

USD 1.87 0.01 0.54%

Cellectis Gross Profit yearly trend continues to be comparatively stable with very little volatility. Gross Profit will likely drop to about 17.1 K in 2024. Gross Profit is the profit Cellectis SA makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2012-09-30

Previous Quarter

3.3 M

Current Value

11.5 M

Quarterly Volatility

8.6 M

Yuan Drop

Covid

Check Cellectis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cellectis' main balance sheet or income statement drivers, such as Depreciation And Amortization of 19.4 M, Interest Expense of 6.7 M or Selling General Administrative of 30.4 M, as well as many indicators such as Price To Sales Ratio of 223, Dividend Yield of 0.0 or PTB Ratio of 3.61. Cellectis financial statements analysis is a perfect complement when working with Cellectis Valuation or Volatility modules.

Check out the analysis of Cellectis Correlation against competitors.

Latest Cellectis' Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Cellectis SA over the last few years. Gross profit is a required income statement account that reflects total revenue of Cellectis SA minus its cost of goods sold. It is profit before Cellectis operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Cellectis' Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cellectis' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 23.95 M

10 Years Trend

Pretty Stable

Compare to Others All Fundamentals

Gross Profit

Timeline

Cellectis Gross Profit Regression Statistics

	Arithmetic Mean	20,855,233
	Geometric Mean	7,258,601
	Coefficient Of Variation	77.14
	Mean Deviation	12,622,586
	Median	21,968,295
	Standard Deviation	16,087,319
	Sample Variance	258.8T
	Range	52.3M
	R-Value	(0.18)
	Mean Square Error	269.3T
	R-Squared	0.03
	Significance	0.51
	Slope	(660,171)
	Total Sum of Squares	3623.2T

Cellectis Gross Profit History

	2024	17.1 K
	2023	18 K
	2022	17.4 M
	2020	37.7 M
	2019	3.8 M
	2018	10 M
	2017	22.6 M

Other Fundumenentals of Cellectis SA

Gross Profit Margin

Cellectis Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Net Receivables	Total Liab	Total Current Assets	Common Stock	Accounts Payable	Intangible Assets	Current Deferred Revenue	Retained Earnings	Short Term Debt	Good Will	Net Tangible Assets	Long Term Debt	Long Term Investments	Short Long Term Debt	Treasury Stock	Property Plant Equipment	Short Term Investments	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.89	-0.72	0.33	0.34	0.94	-0.5	0.22	-0.46	0.12	-0.79	0.19	-0.64	0.93	0.44	0.5	-0.51	0.81	0.45	0.34	0.44	0.72	0.28	0.13	0.1
Total Stockholder Equity	0.89		-0.92	0.13	-0.1	0.94	-0.4	-0.01	-0.39	-0.11	-0.55	-0.21	-0.5	0.92	0.13	0.14	-0.73	0.67	0.06	0.1	0.04	0.4	0.57	0.48	-0.26
Net Debt	-0.72	-0.92		0.07	0.26	-0.91	0.41	0.28	0.4	-0.05	0.24	0.43	0.46	-0.84	0.09	0.17	0.82	-0.6	0.26	-0.12	0.23	-0.14	-0.64	-0.62	0.3
Net Receivables	0.33	0.13	0.07		0.43	0.14	-0.06	0.39	-0.01	0.13	-0.48	0.49	-0.39	0.17	0.2	0.45	0.0	0.38	0.52	0.0	0.41	0.47	-0.17	-0.29	0.33
Total Liab	0.34	-0.1	0.26	0.43		0.14	-0.31	0.38	-0.26	0.64	-0.58	0.88	-0.41	0.22	0.59	0.72	0.43	0.4	0.83	0.68	0.86	0.66	-0.58	-0.76	0.77
Total Current Assets	0.94	0.94	-0.91	0.14	0.14		-0.53	-0.05	-0.5	0.2	-0.57	-0.05	-0.63	0.97	0.21	0.21	-0.66	0.78	0.15	0.35	0.17	0.5	0.43	0.33	-0.01
Common Stock	-0.5	-0.4	0.41	-0.06	-0.31	-0.53		0.38	0.94	-0.34	0.5	-0.26	0.87	-0.57	-0.23	-0.36	0.31	-0.67	-0.34	-0.35	-0.34	-0.45	0.05	0.14	-0.17
Accounts Payable	0.22	-0.01	0.28	0.39	0.38	-0.05	0.38		0.46	-0.26	-0.44	0.32	0.15	-0.02	0.67	0.54	0.24	-0.05	0.51	-0.13	0.56	0.47	-0.05	-0.17	0.11
Intangible Assets	-0.46	-0.39	0.4	-0.01	-0.26	-0.5	0.94	0.46		-0.35	0.46	-0.26	0.76	-0.54	-0.23	-0.36	0.28	-0.64	-0.34	-0.36	-0.34	-0.44	0.07	0.16	-0.19
Current Deferred Revenue	0.12	-0.11	-0.05	0.13	0.64	0.2	-0.34	-0.26	-0.35		-0.01	0.43	-0.4	0.19	0.05	0.08	0.16	0.34	0.2	0.78	0.28	0.17	-0.41	-0.45	0.7
Retained Earnings	-0.79	-0.55	0.24	-0.48	-0.58	-0.57	0.5	-0.44	0.46	-0.01		-0.58	0.6	-0.68	-0.65	-0.81	0.12	-0.63	-0.83	-0.32	-0.79	-0.89	0.07	0.3	-0.27
Short Term Debt	0.19	-0.21	0.43	0.49	0.88	-0.05	-0.26	0.32	-0.26	0.43	-0.58		-0.33	0.07	0.48	0.8	0.61	0.3	0.87	0.51	0.85	0.66	-0.74	-0.91	0.72
Good Will	-0.64	-0.5	0.46	-0.39	-0.41	-0.63	0.87	0.15	0.76	-0.4	0.6	-0.33		-0.67	-0.28	-0.43	0.36	-0.79	-0.41	-0.43	-0.41	-0.54	0.07	0.18	-0.22
Net Tangible Assets	0.93	0.92	-0.84	0.17	0.22	0.97	-0.57	-0.02	-0.54	0.19	-0.68	0.07	-0.67		0.22	0.27	-0.57	0.77	0.27	0.39	0.27	0.55	0.39	0.22	-0.02
Long Term Debt	0.44	0.13	0.09	0.2	0.59	0.21	-0.23	0.67	-0.23	0.05	-0.65	0.48	-0.28	0.22		0.8	0.16	0.3	0.72	0.24	0.84	0.73	-0.23	-0.34	0.37
Long Term Investments	0.5	0.14	0.17	0.45	0.72	0.21	-0.36	0.54	-0.36	0.08	-0.81	0.8	-0.43	0.27	0.8		0.3	0.47	0.91	0.3	0.92	0.9	-0.48	-0.62	0.53
Short Long Term Debt	-0.51	-0.73	0.82	0.0	0.43	-0.66	0.31	0.24	0.28	0.16	0.12	0.61	0.36	-0.57	0.16	0.3		-0.47	0.35	0.2	0.37	0.05	-0.7	-0.71	0.52
Treasury Stock	0.81	0.67	-0.6	0.38	0.4	0.78	-0.67	-0.05	-0.64	0.34	-0.63	0.3	-0.79	0.77	0.3	0.47	-0.47		0.41	0.37	0.41	0.55	0.0	-0.11	0.14
Property Plant Equipment	0.45	0.06	0.26	0.52	0.83	0.15	-0.34	0.51	-0.34	0.2	-0.83	0.87	-0.41	0.27	0.72	0.91	0.35	0.41		0.41	0.96	0.81	-0.46	-0.69	0.53
Short Term Investments	0.34	0.1	-0.12	0.0	0.68	0.35	-0.35	-0.13	-0.36	0.78	-0.32	0.51	-0.43	0.39	0.24	0.3	0.2	0.37	0.41		0.46	0.36	-0.45	-0.52	0.67
Long Term Debt Total	0.44	0.04	0.23	0.41	0.86	0.17	-0.34	0.56	-0.34	0.28	-0.79	0.85	-0.41	0.27	0.84	0.92	0.37	0.41	0.96	0.46		0.83	-0.49	-0.69	0.58
Capital Surpluse	0.72	0.4	-0.14	0.47	0.66	0.5	-0.45	0.47	-0.44	0.17	-0.89	0.66	-0.54	0.55	0.73	0.9	0.05	0.55	0.81	0.36	0.83		-0.21	-0.37	0.54
Net Invested Capital	0.28	0.57	-0.64	-0.17	-0.58	0.43	0.05	-0.05	0.07	-0.41	0.07	-0.74	0.07	0.39	-0.23	-0.48	-0.7	0.0	-0.46	-0.45	-0.49	-0.21		0.93	-0.69
Net Working Capital	0.13	0.48	-0.62	-0.29	-0.76	0.33	0.14	-0.17	0.16	-0.45	0.3	-0.91	0.18	0.22	-0.34	-0.62	-0.71	-0.11	-0.69	-0.52	-0.69	-0.37	0.93		-0.69
Capital Stock	0.1	-0.26	0.3	0.33	0.77	-0.01	-0.17	0.11	-0.19	0.7	-0.27	0.72	-0.22	-0.02	0.37	0.53	0.52	0.14	0.53	0.67	0.58	0.54	-0.69	-0.69

Click cells to compare fundamentals

About Cellectis Financial Statements

Cellectis shareholders use historical fundamental indicators, such as Gross Profit, to determine how well the company is positioned to perform in the future. Although Cellectis investors may analyze each financial statement separately, they are all interrelated. The changes in Cellectis' assets and liabilities, for example, are also reflected in the revenues and expenses on on Cellectis' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Gross Profit	18 K	17.1 K
Gross Profit Margin	0.02	0.02

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Cellectis Stock Analysis

When running Cellectis' price analysis, check to measure Cellectis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectis is operating at the current time. Most of Cellectis' value examination focuses on studying past and present price action to predict the probability of Cellectis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectis' price. Additionally, you may evaluate how the addition of Cellectis to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC